Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: A direct role for B27 heavy chains and not B27-derived peptides

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 101-106

  Khare, Sanjay D ^a   Bull, Michael J ^a   Hanson, Julie ^a   Luthra, Harvinder S ^b   David, Chella S ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HLA SYSTEM; IMMUNOPATHOGENESIS; INCIDENCE; INFLAMMATORY DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SPONDYLOSIS; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ARTHRITIS; BETA 2-MICROGLOBULIN; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-B27 ANTIGEN; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NAIL DISEASES; PEPTIDES;

EID: 0031930270     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brewerton, D. A., F. D. Hart, A. Nicholls, M. Caffrey, D. C. James, and R. D. Sturrock. 1973. Ankylosing spondylitis and HL-A 27. Lancet i:904.
2. Khan, M. A. 1992. An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum. Dis. Clin. North Am. 18:1.
3. 2m: an animal model of HLA-B27 associated human disorders. Cell 63:1099.
4. 2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182:1153.
5. 2m. J. Clin. Invest. 98: 2746.
6. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, M. Zhou, J. L. Fernandez-Sueiro,. E. Balish, and R. E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359.
7. Burmester, G. R., A. Daser, T. Kamradt, A. Krause, N. A. Mitchison, J. Sieper, and N. Wolf. 1995. Immunology of reactive arthritides. Annu. Rev. Immunol. 13:229.
8. Geczy, A. F., K. Alexander, H. V. Bashir, J. P. Edmonds, L. Upfold, and J. S. Sullivan. 1983. HLA-B27, Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol. Rev. 70:23.
9. Benjamin, R., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11:137.
10. Scofield, R. H., W. L. Warren, G. Koelsch, and J. B. Harley. 1993. A hypothesis for the HLA-B27 dysregulation in spondyloarthropathy: contribution from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc. Natl. Acad. Sci. USA 90:9330.
11. Scofield, R. H., B. Kurien, T. Gross, W. L. Warren, and J. B. Harley. 1995. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 345:1542.
12. Sieper, J., and G. Kingsley. 1996. Recent advances in the pathogenesis of reactive arthritis. Immunol. Today 17:160.
13. Parham, P. 1997. Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis. Immunol. Rev. 154: 137.
14. Hermann, E., B. Fleischer, W. J. Mayet, T. Poralla, and K. H. Meyer zum Buschenfelde. 1989. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis. Clin. Exp. Immunol. 75:365.
15. Viner, N. J., L. C. Bailey, P. F. Life, P. A. Bacon, and J. S. H. Gaston. 1991. Isolation of Yersinia-specific T-cell clones from the synovial membrane and synovial fluid of patients with reactive arthritis. Arthritis Rheum. 34:1151.
16. Hermann, E., W. J. Mayet, H. Thomssen, J. Sieper, T. Poralla, K. H. Meyer zum Buschenfelde, and B. Fleischer. 1992. HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia-induced Reiter's disease. J. Rheumatol. 19:1243.
17. Hermann, E., D. T. Yu, K. H. Meyer zum Buschenfelde, and B. Fleischer. 1993. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342:646.
18. Hermann, E. M., R. Duchmann, E. May, B. Ackermann, and K. H. Meyer zum Buschenfelde. 1996. The T cell receptor (TCR) in HLA-B27-restricted T cell responses: an introduction. Clin. Rheumatol. 15(Suppl. 1):86.
19. Lopez-Larrea, C., S. Gonzalez-Roces, and V. Alvarez. 1996. HLA-B27 structure, function and disease association. Curr. Opin. Rheumatol. 8:296.
20. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
21. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137:2299.
22. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Anna. Rev. Immunol. 11:729.
23. Simmons, W. A., L. Y. W. Leong, N. Satumtira, G. W. Butcher, J. C. Howard, J. A. Richardson, C. A. Slaughter, R. E. Hammer, and J. D. Taurog. 1996. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J. Immunol. 156:1661.
24. 2-microglobulin mice is biased towards reactivity against self-major histocompatibility complex I. J. Exp. Med. 179:661.
25. 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self epitope by MHC class I α-chain to a cross reactive CTL clone. J. Immunol. 153:4070.
26. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
27. Yewdell, J. W., J. R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637.
28. Carbone, F. R., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377.
29. Rock, K. L., S. Gamble, and L. Rothstein. 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918.
30. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359.
31. Norbury, C. C., L. J. Hewlett, A. R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783.
32. Jondal, M., M. Schirmbeck, and Jörg Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
33. Malaviya, R., N. J. Twesten, E. A. Ross, S. N. Abraham, and J. D. Pfeifer. 1996. Mast cells process bacterial antigens through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156:1490.
34. Benjamin, R. J., J. A. Madrigal, and P. Parham. 1991. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 351:74.
35. Kurts, C., W. R. Heath, F. R. Carbone, J. Allison, J. F. A. P. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigen in vivo. J. Exp. Med. 184:923.
36. Yuokko, J., H. Reijonen, J. Ilonen, K. Anttila, S. Kikkari, T. Mottonen, U. Yli-Kerttula, and A. Toivanen. 1997. Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis. Ann. Rheum. Dis. 56:37.